β¨ Government Notices
NEW ZEALAND GAZETTE, No. 143 β 27 NOVEMBER 2014
Dated at Wellington this 20th day of November 2014.
DON GRAY, Acting Director-General of Health.
New Zealand Gazette, 17 October 2013, No. 143, page 3909
2014-go7228
Notice Under Clause 11 of Schedule 5 of the Overseas Investment Regulations 2005
For the period 1 January 2015 to the close of 31 December 2015, the threshold for Australian non-government investments is $496 million, and the threshold for Australian government investments is $104 million.
Dated this 25th day of November 2014.
ANNELIES McCLURE, Manager, Overseas Investment Office.
2014-go7322
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Humira
Active Ingredient: Adalimumab 50mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: AbbVie Limited
Manufacturers: Vetter Pharma-Fertigung GmbH & Co KG, Ravensburg, Germany
Vetter Pharma-Fertigung GmbH & Co KG, Langenargen, Germany
Product: Humira
Active Ingredient: Adalimumab 20mg/0.4mL
Dosage Form: Solution for injection
New Zealand Sponsor: AbbVie Limited
Manufacturer: Vetter Pharma-Fertigung GmbH & Co KG, Ravensburg, Germany
Product: Humira Pen
Active Ingredient: Adalimumab 50mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: AbbVie Limited
Manufacturers: Vetter Pharma-Fertigung GmbH & Co KG, Ravensburg, Germany
Aesica Queenborough Limited, Kent, United Kingdom
Vetter Pharma-Fertigung GmbH & Co KG, Langenargen, Germany
Dated this 21st day of November 2014.
CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
2014-go7237
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Adempas
Active Ingredient: Riociguat 0.5mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Bayer New Zealand Limited
Manufacturer: Bayer Pharma AG, Leverkusen, Germany
66
Next Page →
β¨ LLM interpretation of page content
π° Overseas Investment Thresholds for Australian Investments
π° Finance & Revenue25 November 2014
Overseas Investment, Thresholds, Australian Investments
- ANNELIES McCLURE, Manager, Overseas Investment Office
π₯ Consent to Distribute New Medicines (Humira)
π₯ Health & Social Welfare21 November 2014
Medicines, Consent, Humira, Adalimumab
- CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health
π₯ Consent to Distribute New Medicines (Adempas)
π₯ Health & Social Welfare21 November 2014
Medicines, Consent, Adempas, Riociguat
- CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health
NZ Gazette 2014, No 143